glp 1 super bowl ad It truly was the GLP-1 bowl. 🫣 With several brands advertising in the big game, the uphill battle for brand differentiation in the weight loss drug market has never been more intense Ro serves up Super Bowl

Liraglutide also suppressed NLRP3 transcription

The GLP-1 Market size was valued at USD 52.82 billion in 2025 and is expected to grow at a CAGR of 10.9% from 2026 to 2034.

New content online: The role of GLP1 receptor agonists in adult-onset type 1 diabetes mellitus

The GLP-1 receptor agonist drug class has revolutionized obesity treatment, but key unmet needs persist

These trends suggest that GLP-1s are reshaping treatment patterns most significantly in markets where few alternatives exist and where their effectiveness is increasingly valued

Patient-specific compounded oral GLP-1s through licensed pharmacies are a separate lawful category